Diabetes 54:S108-S113, 2005
© 2005 by the American Diabetes Association, Inc.
Section III: Inflammation and ß-Cell Death |
Mechanisms of ß-Cell Death in Type 2 Diabetes
Marc Y. Donath1,
Jan A. Ehses1,
Kathrin Maedler1,
Desiree M. Schumann1,
Helga Ellingsgaard1,
Elisabeth Eppler2, and
Manfred Reinecke2
1 Division of Endocrinology and Diabetes, University Hospital Zurich, Zurich, Switzerland
2 Division of Neuroendocrinology, Institute of Anatomy, University of Zurich, Zurich, Switzerland
A decrease in the number of functional insulin-producing ß-cells contributes to the pathophysiology of type 2 diabetes. Opinions diverge regarding the relative contribution of a decrease in ß-cell mass versus an intrinsic defect in the secretory machinery. Here we review the evidence that glucose, dyslipidemia, cytokines, leptin, autoimmunity, and some sulfonylureas may contribute to the maladaptation of ß-cells. With respect to these causal factors, we focus on Fas, the ATP-sensitive K+ channel, insulin receptor substrate 2, oxidative stress, nuclear factor- B, endoplasmic reticulum stress, and mitochondrial dysfunction as their respective mechanisms of action. Interestingly, most of these factors are involved in inflammatory processes in addition to playing a role in both the regulation of ß-cell secretory function and cell turnover. Thus, the mechanisms regulating ß-cell proliferation, apoptosis, and function are inseparable processes.
Address correspondence and reprint requests to Marc Y. Donath, MD, Division of Endocrinology and Diabetes, Department of Medicine, University Hospital, CH-8091 Zurich, Switzerland. E-mail: marc.donath{at}usz.ch
Abbreviations:
ER, endoplasmic reticulum; FLIP, FLICE inhibitory protein; IL, interleukin; KATP channel, ATP-sensitive K+ channel; NF, nuclear factor

CiteULike Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
H. Ghanaat-Pour, Z. Huang, M. Lehtihet, and A. Sjoholm
Global expression profiling of glucose-regulated genes in pancreatic islets of spontaneously diabetic Goto-Kakizaki rats
J. Mol. Endocrinol.,
August 1, 2007;
39(2):
135 - 150.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Hambrock, C. B. de Oliveira Franz, S. Hiller, A. Grenz, S. Ackermann, D. U. Schulze, G. Drews, and H. Osswald
Resveratrol Binds to the Sulfonylurea Receptor (SUR) and Induces Apoptosis in a SUR Subtype-specific Manner
J. Biol. Chem.,
February 2, 2007;
282(5):
3347 - 3356.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Y. Donath and J. A. Ehses
Type 1, type 1.5, and type 2 diabetes: NOD the diabetes we thought it was
PNAS,
August 15, 2006;
103(33):
12217 - 12218.
[Full Text]
[PDF]
|
 |
|
Copyright © 2005 by the American Diabetes Association.
|
|
| |
|